A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42

Leukemia

Volumn 20, Issue 2, 2006, Pages 224-229

  Paulsson, Kajsa ^a   Bekassy A N ^a   Olofsson, T ^a   Mitelman, F ^a   Johansson, B ^a   Panagopoulos, I ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myeloid leukemia; Cryptic translocation; RUNX1; USP42

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEINASE; TRANSCRIPTION FACTOR RUNX1; UBIQUITIN SPECIFIC PROTEASE 42; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHIMERA; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; ENZYME ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE FUSION; GENE MAPPING; GENE REARRANGEMENT; HUMAN; INTRON; LEUKEMIA REMISSION; LEUKEMOGENESIS; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 31444449609     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404076     Document Type: Article

References (34)

1. Rowley JD. Chromosome translocations: Dangerous liaisons revisited. Nat Rev Cancer 2001; 1: 245-250.
2. Johansson B, Mertens F, Mitelman F. Primary vs. secondary neoplasia-associated chromosomal abnormalities - balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 1996; 16: 155-163.
3. Johansson B, Mertens F, Mitelman F. Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia. Ann Med 2004; 36: 492-503.
4. Gotlib J, Cools J, Malone III JM, Schrier SL, Gilliland DG, Coutré SE. The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: Implications for diagnosis, classification, and management. Blood 2004; 103: 2879-2891.
5. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991; 88: 10431-10434.
6. Song W-J, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 166-175.
7. Osato M. Point mutations in the RUNX1/AML1 gene: Another actor in RUNX leukemia. Oncogene 2004; 23: 4284-4296.
8. Kurokawa M, Hirai H. Role of AML1/Runx1 in the pathogenesis of hematological malignancies. Cancer Sci 2003; 94: 841-846.
9. Liu P, Tarlé SA, Hajra A, Claxton DF, Marlton P, Freedman M et al. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041-1044.
10. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995; 92: 4917-4921.
11. Mikhail FM, Coignet L, Hatem N, Mourad ZI, Farawela HM, El Kaffash DM et al. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 2004; 39: 110-118.
12. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993; 12: 2715-2721.
13. Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J et al. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci USA 1994; 91: 4004-4008.
14. Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y et al. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8 (ETO) family. Blood 1998; 91: 4028-4037.
15. Zhang Y, Emmanuel N, Kamboj G, Chen J, Shurafa M, Van Dyke DL et al. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22). Genes Chromosomes Cancer 2004; 40: 365-370.
16. Chan EM, Comer EM, Brown FC, Richkind KE, Holmes ML, Chong BH et al. AML1-FOG2 fusion protein in myelodysplasia. Blood 2005; 105: 4523-4526.
17. Quesada V, Díaz-Perales A, Gutiérrez-Fernández A, Garabaya C, Cal S, López-Otín C. Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. Biochem Biophys Res Commun 2004; 314: 54-62.
18. Lie SO, Abrahamsson J, Clausen N, Forestier E, Hasle H, Hovi L et al. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: Results of NOPHO-AML trials. Br J Haematol 2003; 122: 217-225.
19. Tanke HJ, Wiegant J, van Gijlswijk RPM, Bezrookove V, Pattenier H, Heetebrij RJ et al. New strategy for multi-colour fluorescence in situ hybridisation: COBRA: COmbined Binary RAtio labelling. Eur J Hum Genet 1999; 7: 2-11.
20. Scherer SW, Green ED. Human chromosome 7 circa 2004: A model for structural and functional studies of the human genome. Hum Mol Genet 2004; 13: R303-R313.
21. Slater RM, v Drunen E, Kroes WG, Weghuis DO, van den Berg E, Smit EM et al. t(7;12)(q36;p13) and t(7;12)(q32;p13) - translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Leukemia 2001; 15: 915-920.
22. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001; 97: 3581-3588.
23. Saglio G, Storlazzi CT, Giugliano E, Surace C, Anelli L, Rege-Cambrin G et al. A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: Possible involvement in the genesis of the Philadelphia chromosome translocation. Proc Natl Acad Sci USA 2002; 99: 9882-9887.
24. Graner E, Tang D, Rossi S, Baron A, Migita T, Weinstein LJ et al. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 2004; 5: 253-261.
25. Liu L-Q, Ilaria R, Kingsley PD, Iwama A, van Etten RA, Palis J et al. A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation. Mol Cell Biol 1999; 19: 3029-3038.
26. De Pittá C, Tombolan L, Campo Dell'Orto M, Accordi B, te Kronnie G, Romualdi C et al. A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia. Haematologica 2005; 90: 890-898.
27. Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen C-J, Neff JR et al. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene 2005; 24: 3419-3426.
28. Roulston D, Espinosa III R, Nucifora G, Larson RA, Le Beau MM, Rowley JD. CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: Association with prior therapy. Blood 1998; 92: 2879-2885.
29. Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBPαB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood 2000; 96: 2862-2869.
30. Huang G, Shigesada K, Ito K, Wee H-J, Yokomizo T, Ito Y. Dimerization with PEBP2β protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J 2001; 20: 723-733.
31. Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: Evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 2000; 97: 2145-2150.
32. Fu J-F, Hsu J-J, Tang T-C, Shih L-Y. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia. Genes Chromosomes Cancer 2003; 37: 214-219.
33. Jaju RJ, Fidler C, Haas OA, Strickson AJ, Watkins F, Clark K et al. A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood 2001; 98: 1264-1267.
34. Bullinger L, Döhner K, Bair E, Fröhling S, Schlenk RF, Tibshirani R et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605-1616.